Literature DB >> 30999939

Liberal versus conservative oxygen therapy in critically ill patients: using the fragility index to determine robust results.

Maria Vargas1, Giuseppe Servillo2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30999939      PMCID: PMC6474041          DOI: 10.1186/s13054-018-2165-z

Source DB:  PubMed          Journal:  Crit Care        ISSN: 1364-8535            Impact factor:   9.097


× No keyword cloud information.
Guidelines on the use of supplemental oxygen for various acute illnesses in adults are contradictory and inconsistent, and at this time no high-quality evidence base exists [1]. Although many randomized controlled trials (RCTs) comparing liberal versus conservative oxygen for various critical conditions have been done, the trial data are not conclusive [2]. With this in mind, we read with great interest the just published systematic review and meta-analysis by Chu et al. [2] on mortality and morbidity in acutely ill adults treated with liberal versus conservative oxygen therapy. The authors stated that liberal supplemental oxygen was harmful and associated with a dose-dependent increased risk of short-term and long-term mortality [2]. Chu et al. performed an excellent statistical analysis and a robust trial sequential analysis. Our major concern is about the fragility of the included trials. As we know from the current literature, RCTs are designed to assess objectively the safety and efficacy of a specific intervention [3]. Recently the fragility index (FI), an intuitive measure of the robustness of RCTs, was introduced in the critical care area [4]. Studies with larger FI values have more robust findings compared with the studies with poor FI values [3, 4]. We evaluated the FI of the RCTs included in the meta-analysis by Chu et al. using a two-by-two contingency table and p value produced by Fisher exact test [4]. Surprisingly, we found that 18 RCTs had a FI of 0 while the unpublished data from trial NCT00414726 had a FI of 2 (Table 1). Furthermore, we looked at the statistical significance of the mortality reported in the included study and found that only the study by Girardis et al. [5] reached statistical significance in the primary outcome.
Table 1

Fragility index calculated for the study included in the systematic review and meta-analysis by Chu et al. [1]

StudySettingLiberal group (FiO2 0.52 CI:0.39-0.85)Conservative group (FiO2 0.21 CI:0.21-0.50)p value for mortality in each studyFragility index n (p)
Ali et al. (2014) [6]Stroke5/1554/1460.990 (1)
Roffe et al. (2017) [7]Stroke50/266845/26680.750 (0.506)
Ronning et al. (1999) [8]Stroke36/29227/2580.540 (0.506)
Singhal et al. (2005) [9]Stroke0/91/7NS0 (0.438)
NCT00414726Stroke14/434/420.082 (0.072)
Shi et al. (2017) [10]Stroke0/90/9NS0 (1)
NCT02378454 (2015)Sepsis3/252/25NS0 (1)
Butler et al. (1987) [11]Limb ischemia1/170/22NS0 (0.436)
Schietroma et al. (2016) [12]Perforated peptic ulcer2/1194/1200.420 (0648)
NCT02687217Acute appendicitis0/300/30NS0 (1)
Girardis et al. (2016) [5]Critical illness80/24358/2350.010 (0.055)
Panwar et al. (2016) [13]Critical illness12/5113/530.440 (1)
Hofmann et al. (2017) [14]Myocardial infarction53/331144/33180.080 (0.359)
Khoshnood et al. (2015) [15]Myocardial infarction3/853/75NS0 (1)
Kuisma et al. (2006) [16]Cardiac arrest4/144/14NS0 (1)
Rawles et al. (1976) [17]Myocardial infarction9/1053/95NS0 (0.140)
Stub et al. (2012) [18]Myocardial infarction5/13211/132NS0 (0.204)
Ukholkina et al. (2005) [19]Myocardial infarction1/580/79NS0 (0.428)
Young et al. (2014) [20]Cardiac arrest5/94/8NS0 (1)

NS not significant

Fragility index calculated for the study included in the systematic review and meta-analysis by Chu et al. [1] NS not significant The authors stated that their data may have potential implications in clinical practice of acutely ill patients. According to our results, critical care clinicians should be wary of basing decisions about conservative or liberal oxygen therapy on the available information from this meta-analysis [1] including trials with a low FI. Furthermore, these results came from fragile and not statistically significant RCTs. Maybe it is time to add the FI and/or statistical significance of the considered outcome as criteria for the evaluation of the quality of evidence.
  19 in total

1.  HyperOxic Therapy OR NormOxic Therapy after out-of-hospital cardiac arrest (HOT OR NOT): a randomised controlled feasibility trial.

Authors:  Paul Young; Mark Bailey; Rinaldo Bellomo; Stephen Bernard; Bridget Dicker; Ross Freebairn; Seton Henderson; Diane Mackle; Colin McArthur; Shay McGuinness; Tony Smith; Andrew Swain; Mark Weatherall; Richard Beasley
Journal:  Resuscitation       Date:  2014-09-28       Impact factor: 5.262

2.  A randomized controlled trial of oxygen therapy in acute myocardial infarction Air Verses Oxygen In myocarDial infarction study (AVOID Study).

Authors:  Dion Stub; Karen Smith; Stephen Bernard; Janet E Bray; Michael Stephenson; Peter Cameron; Ian Meredith; David M Kaye
Journal:  Am Heart J       Date:  2012-03       Impact factor: 4.749

Review 3.  The statistical significance of randomized controlled trial results is frequently fragile: a case for a Fragility Index.

Authors:  Michael Walsh; Sadeesh K Srinathan; Daniel F McAuley; Marko Mrkobrada; Oren Levine; Christine Ribic; Amber O Molnar; Neil D Dattani; Andrew Burke; Gordon Guyatt; Lehana Thabane; Stephen D Walter; Janice Pogue; P J Devereaux
Journal:  J Clin Epidemiol       Date:  2014-02-05       Impact factor: 6.437

Review 4.  The Fragility Index in Multicenter Randomized Controlled Critical Care Trials.

Authors:  Elliott E Ridgeon; Paul J Young; Rinaldo Bellomo; Marta Mucchetti; Rosalba Lembo; Giovanni Landoni
Journal:  Crit Care Med       Date:  2016-07       Impact factor: 7.598

5.  Oxygen Therapy in Suspected Acute Myocardial Infarction.

Authors:  Robin Hofmann; Stefan K James; Tomas Jernberg; Bertil Lindahl; David Erlinge; Nils Witt; Gabriel Arefalk; Mats Frick; Joakim Alfredsson; Lennart Nilsson; Annica Ravn-Fischer; Elmir Omerovic; Thomas Kellerth; David Sparv; Ulf Ekelund; Rickard Linder; Mattias Ekström; Jörg Lauermann; Urban Haaga; John Pernow; Ollie Östlund; Johan Herlitz; Leif Svensson
Journal:  N Engl J Med       Date:  2017-08-28       Impact factor: 91.245

6.  The effect of adjuvant oxygen therapy on transcutaneous pO2 and healing in the below-knee amputee.

Authors:  C M Butler; R O Ham; K Lafferty; L T Cotton; V C Roberts
Journal:  Prosthet Orthot Int       Date:  1987-04       Impact factor: 1.895

7.  A pilot study of normobaric oxygen therapy in acute ischemic stroke.

Authors:  Aneesh B Singhal; Thomas Benner; Luca Roccatagliata; Walter J Koroshetz; Pamela W Schaefer; Eng H Lo; Ferdinando S Buonanno; R Gilberto Gonzalez; A Gregory Sorensen
Journal:  Stroke       Date:  2005-03-10       Impact factor: 7.914

8.  Effect of Routine Low-Dose Oxygen Supplementation on Death and Disability in Adults With Acute Stroke: The Stroke Oxygen Study Randomized Clinical Trial.

Authors:  Christine Roffe; Tracy Nevatte; Julius Sim; Jon Bishop; Natalie Ives; Phillip Ferdinand; Richard Gray
Journal:  JAMA       Date:  2017-09-26       Impact factor: 56.272

9.  Supplemental Peri-Operative Oxygen and Incision Site Infection after Surgery for Perforated Peptic Ulcer: A Randomized, Double-Blind Monocentric Trial.

Authors:  Mario Schietroma; Emanuela Marina Cecilia; Giuseppe De Santis; Francesco Carlei; Beatrice Pessia; Gianfranco Amicucci
Journal:  Surg Infect (Larchmt)       Date:  2015-11-10       Impact factor: 2.150

10.  The stroke oxygen pilot study: a randomized controlled trial of the effects of routine oxygen supplementation early after acute stroke--effect on key outcomes at six months.

Authors:  Khalid Ali; Anushka Warusevitane; Frank Lally; Julius Sim; Sheila Sills; Sarah Pountain; Tracy Nevatte; Martin Allen; Christine Roffe
Journal:  PLoS One       Date:  2013-06-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.